Literature DB >> 10721744

Bioresorbable bone graft substitutes of different osteoconductivities: a histologic evaluation of osteointegration of poly(propylene glycol-co-fumaric acid)-based cement implants in rats.

K U Lewandrowski1, J D Gresser, D L Wise, D J Trantol.   

Abstract

Bioresorbable bone graft substitutes may significantly reduce the disadvantages associated with autografts, allografts and other synthetic materials currently used in bone graft procedures. We investigated the biocompatibility and osteointegration of a bioresorbable bone graft substitute made from the unsaturated polyester poly(propylene-glycol-co-fumaric acid), or simply poly(propylene fumarate), PPF, which is crosslinked in the presence of soluble and insoluble calcium filler salts. Four sets of animals each having three groups of 8 were evaluated by grouting bone graft substitutes of varying compositions into 3-mm holes that were made into the anteromedial tibial metaphysis of rats. Four different formulations varying as to the type of soluble salt filler employed were used: set 1--calcium acetate, set 2--calcium gluconate, set 3--calcium propionate, and set 4--control with hydroxapatite, HA, only. Animals of each of the three sets were sacrificed in groups of 8 at postoperative week 1, 3, and 7. Histologic analysis revealed that in vivo biocompatibility and osteointegration of bone graft substitutes was optimal when calcium acetate was employed as a soluble salt filler. Other formulations demonstrated implant surface erosion and disintegration which was ultimately accompanied by an inflammatory response. This study suggested that PPF-based bone graft substitutes can be designed to provide an osteoconductive pathway by which bone will grow in faster because of its capacity to develop controlled porosities in vivo. Immediate applicability of this bone graft substitute, the porosity of which can be tailored for the reconstruction of defects of varying size and quality of the recipient bed, is to defects caused by surgical debridement of infections, previous surgery, tumor removal, trauma, implant revisions and joint fusion. Clinical implications of the relation between developing porosity, resulting osteoconduction, and bone repair in vivo are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721744     DOI: 10.1016/s0142-9612(99)00179-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  22 in total

1.  Development of non-invasive Raman spectroscopy for in vivo evaluation of bone graft osseointegration in a rat model.

Authors:  Paul I Okagbare; Francis W L Esmonde-White; Steven A Goldstein; Michael D Morris
Journal:  Analyst       Date:  2010-10-06       Impact factor: 4.616

2.  Historic and current strategies in bone tissue engineering: do we have a hope in Hench?

Authors:  Eileen Gentleman; Julia M Polak
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

3.  Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation.

Authors:  Eileen Gentleman; Robin J Swain; Nicholas D Evans; Suwimon Boonrungsiman; Gavin Jell; Michael D Ball; Tamaryn A V Shean; Michelle L Oyen; Alexandra Porter; Molly M Stevens
Journal:  Nat Mater       Date:  2009-07-26       Impact factor: 43.841

4.  Visualization of vascular ultrastructure during osteogenesis by tissue engineering technique.

Authors:  Kaigang Zhang; Bingfang Zeng; Changqing Zhang
Journal:  Front Med China       Date:  2007-05

5.  A poly(propylene glycol-co-fumaric acid) based bone graft extender for lumbar spinal fusion: in vivo assessment in a rabbit model.

Authors:  David D Hile; Frank Kandziora; Kai-Uwe Lewandrowski; Stephen A Doherty; Michael P Kowaleski; Debra J Trantolo
Journal:  Eur Spine J       Date:  2005-08-13       Impact factor: 3.134

6.  Sintering of biphasic calcium phosphates.

Authors:  O Brown; M McAfee; S Clarke; F Buchanan
Journal:  J Mater Sci Mater Med       Date:  2010-03-16       Impact factor: 3.896

7.  In vivo assessment of hydroxyapatite and silicate-substituted hydroxyapatite granules using an ovine defect model.

Authors:  N Patel; R A Brooks; M T Clarke; P M T Lee; N Rushton; I R Gibson; S M Best; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  2005-05       Impact factor: 3.896

8.  Antimicrobial Formulations of Absorbable Bone Substitute Materials as Drug Carriers Based on Calcium Sulfate.

Authors:  D Pförringer; A Obermeier; M Kiokekli; H Büchner; S Vogt; A Stemberger; R Burgkart; M Lucke
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  Antibiotic modification of native grafts: improving upon nature's scaffolds.

Authors:  Constantinos Ketonis; Christopher S Adams; Stephanie Barr; Amiethab Aiyer; Irving M Shapiro; Javad Parvizi; Noreen J Hickok
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

10.  Microstructure and biomechanical characteristics of bone substitutes for trauma and orthopaedic surgery.

Authors:  Esther M M Van Lieshout; Gerdine H Van Kralingen; Youssef El-Massoudi; Harrie Weinans; Peter Patka
Journal:  BMC Musculoskelet Disord       Date:  2011-02-02       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.